Products for Research Use Only

TX-1918

CAT: 0804-HY-112393-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-112393-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
TX-1918 is an inhibitor for eukaryotic elongation factor 2 kinase (eEF2-K) and Src kinase with IC50 of 0.44 and 4.4 μM, respectively. TX-1918 exhibits cytotoxicity in cell HepG2 and HCT116, with IC50 of 2.07 and 230 μM, respectively. TX-1918 inhibits the C-terminal domain of HIV-1 CA (CA CTD) (IC50 =3.81 μM), and inhibits the viral replication (IC50 =15.16 μM) [1][2].
CAS Number
503473-32-3
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
HIV; PKA; PKC; Src
Type
Reference compound
Related Pathways
Anti-infection; Epigenetics; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt; TGF-beta/Smad
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/tx-1918.html
Smiles
O=C1/C(C(C=C1)=O)=C\C2=CC(C)=C(O)C(C)=C2
Molecular Formula
C14H12O3
Molecular Weight
228.24
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Hori H, et al., TX-1123: an antitumor 2-hydroxyarylidene-4-cyclopentene-1,3-dione as a protein tyrosine kinase inhibitor having low mitochondrial toxicity. Bioorg Med Chem. 2002 Oct;10 (10) :3257-65.|[2]Zhang DW, et al., A HTRF based competitive binding assay for screening specific inhibitors of HIV-1 capsid assembly targeting the C-Terminal domain of capsid. Antiviral Res. 2019 Sep;169:104544.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported